Potential of MALDI-TOF MS as an alternative approach for capsular typing Streptococcus pneumoniae isolates

Tatiana C A Pinto1, Natalia S Costa1, Luciana F S Castro1

  • 1Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Scientific Reports
|March 29, 2017
PubMed

Insights

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) shows promise for identifying Streptococcus pneumoniae capsular types. This method offers a rapid, cost-effective alternative for clinical laboratories.

Area of Science:

  • Microbiology
  • Clinical Diagnostics
  • Mass Spectrometry

Background:

  • Streptococcus pneumoniae has over 90 capsular types, crucial for epidemiology and vaccine impact assessment.
  • Traditional typing methods (serology, PCR) are costly, laborious, and can lack precision.
  • Current typing is largely confined to research labs, limiting clinical application.

Purpose of the Study:

  • To evaluate MALDI-TOF MS as an alternative method for pneumococcal capsular type determination.
  • To assess the feasibility of using MALDI-TOF MS for routine clinical laboratory application.

Main Methods:

  • Analyzed 416 Streptococcus pneumoniae isolates from serotypes 6A, 6B, 6C, 9N, 9V, and 14.
  • Utilized a formic acid and acetonitrile extraction protocol for MALDI-TOF MS analysis.
  • Generated spectra (2,000-20,000 m/z) using a Bruker Microflex LT mass spectrometer and analyzed with BioNumerics v7.6.

Main Results:

  • Isolates were successfully classified by capsular type using a Neighbor Joining tree.
  • Discrimination of serotypes was achieved through the presence/absence of 14 specific biomarkers.
  • MALDI-TOF MS demonstrated high discriminatory power for the investigated pneumococcal serotypes.

Conclusions:

  • MALDI-TOF MS is a viable and promising tool for pneumococcal strain typing.
  • The method offers a rapid and cost-effective solution for routine use in clinical settings.
  • This technique can improve epidemiological surveillance and vaccine impact studies.